Patent · US Active

5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same

US9416117B2 · kind B2 · utility

11Cited by
17References
35Claims
0Family size

Assignee

Inventor

Key dates

Filing dateFeb 6, 2015
Grant dateAug 16, 2016
Priority date
Expiry dateFeb 6, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides 5-deuterium-enriched 2,4-thiazolidinediones (e.g., 5-[4-[2-(5-ethyl-2-pyridyl)-2-oxoethoxy]benzyl]-5-deutero-thiazolidine-2,4-dione), deuterated derivatives thereof, stereoisomers thereof, pharmaceutically acceptable salt forms thereof, and methods of treatment using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.